MK 571

3-[({3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}{[3-(dimethylamino)-3-oxopropyl]sulfanyl}methyl)sulfanyl]propanoic acid

AXUZQJFHDNNPFG-UXBLZVDNSA-N CHEBI:6619 11 Reactome links 2 studies

2 Observed studies

2 Observed diff profiles

11 Reactome pathways

Metabolite details

Identifier: AXUZQJFHDNNPFG-UXBLZVDNSA-N
InChI Key: AXUZQJFHDNNPFG-UXBLZVDNSA-N
IUPAC name: 3-[({3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}{[3-(dimethylamino)-3-oxopropyl]sulfanyl}methyl)sulfanyl]propanoic acid
Preferred name: MK 571
INN name: —
Synonym: L-660711
ChEBI: CHEBI:6619

Reactome pathways

R-HSA-162582 - Signal Transduction
R-HSA-1643685 - Disease
R-HSA-372790 - Signaling by GPCR
R-HSA-373076 - Class A/1 (Rhodopsin-like receptors)
R-HSA-391903 - Eicosanoid ligand-binding receptors
R-HSA-391906 - Leukotriene receptors
R-HSA-500792 - GPCR ligand binding
R-HSA-5663205 - Infectious disease
R-HSA-9679191 - Potential therapeutics for SARS
R-HSA-9679506 - SARS-CoV Infections
R-HSA-9824446 - Viral Infection Pathways

Observed in studies

Observed in differential profiles